Recent Articles from GlobeNewswire

HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), a leading space technology, infrastructure, and services company, today announced its financial results for the fourth quarter and full-year ended December 31, 2025.

WASHINGTON, D.C., March 19, 2026 (GLOBE NEWSWIRE) -- NeuroRPM, a digital health company focused on Parkinson’s disease monitoring, today announced that its FDA-cleared wearable platform will be used for digital biomarker monitoring in Annovis Bio’s ANVS-25002 open-label Parkinson’s disease clinical trial. NeuroRPM’s platform uses the Apple Watch to passively collect and analyze movement data during daily activities, providing continuous measurement of key Parkinson’s motor symptoms.

PHILADELPHIA, March 19, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, today announced a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22, 2026 in San Diego, CA. The presentation will highlight preclinical data regarding the Company’s asset, CT-202, a Nectin-4 x CD3 TCE.

MALVERN, Pa., March 19, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today announced a partnership with NeuroRPM, a digital health technology company, to implement a new FDA-cleared artificial intelligence (AI) platform that collects movement data for symptom and disease management in its ongoing Parkinson’s study.

Equinor ASA (OSE: EQNR, NYSE: EQNR) publishes its annual report for 2025.

SAN DIEGO and TORONTO, March 19, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF) today announced that Institutional Shareholder Services (“ISS”), a leading independent proxy advisory firm, has recommended that Aptose shareholders (“Shareholders”) vote ”FOR” a special resolution (the “Arrangement Resolution”) to approve the previously announced arrangement (the “Arrangement”) pursuant to which Hanmi Pharmaceutical Co. Ltd. (“Hanmi”) and HS North America Ltd., a wholly owned subsidiary of Hanmi (“Hanmi Purchaser” and together with Hanmi, the “Hanmi Purchasers”), will acquire all of the issued and outstanding common shares of Aptose (“Common Shares”) that are not currently owned or controlled by the Hanmi Purchasers or their respective affiliates.

CAMBRIDGE, Mass., March 19, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced upcoming scientific presentations at the 2026 American Academy of Dermatology (AAD) Annual Meeting, taking place March 27-31. Late-breaking data from Part A (Phase 2) of the AMETHYST Phase 2/3 study will be presented that highlight litifilimab’s effect on cutaneous lupus erythematosus (CLE) disease activity. Litifilimab is a potential first in-class, monoclonal antibody (mAb) targeting blood dendritic cell antigen 2 (BDCA2) and was the first investigational therapy to show positive results in CLE, as shown in the Phase 2 LILAC study. Additional presentations at AAD will provide new insights into measures used to assess the severity of CLE disease activity in both clinical trials and clinical practice.

Pennsylvania Agency Advances Non-Lethal Response Strategy with Latest BolaWrap Technology and State’s First WrapTactics Learning Management System Implementation

Property managers lowering credit thresholds to maintain occupancy may need new strategies to help mitigate risk

Maturing data from the ongoing registrational intent Phase 2b ACR-368 study showed a confirmed overall response rate (cORR) of 52% in serous endometrial cancer (EC)

Health care technology executive brings more than three decades of leadership experience and a personal connection to digestive health.

Conference call will be held today, Thursday, March 19 at 9:00 am ET

FRAUENFELD, Switzerland, March 19, 2026 (GLOBE NEWSWIRE) -- Aebi Schmidt Group (NASDAQ: AEBI) (“Aebi Schmidt”, the “Group”, or the “Company”), a world-class specialty vehicles leader, reports strong EBITDA growth and record order backlog, providing a solid foundation to the Group to accelerate order conversion and grow profitability in 2026.

Honoring visionary partners and delivering transformative impact, the UNCF New England "A Mind Is..."® Gala continues to bridge the gap between potential and opportunity

TORONTO, March 19, 2026 (GLOBE NEWSWIRE) -- illumin Holdings Inc. (TSX: ILLM, OTCQB: ILLMF) and Full Stack Big Data (FSBD) today announced a strategic partnership designed to help advertisers expand meaningful reach, reduce waste and turn more media spend into measurable performance while operating in a privacy-safe advertising environment.

AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026

NEW YORK and SYDNEY, March 19, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a recognized global leader in medical cannabis and a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), today announced its largest portfolio expansion in Australia to date. The expanded medical cannabis offering reinforces Tilray Medical’s long-term commitment to the Australian market and supports increased patient access to regulated, clinically supported medical cannabis products.

LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced it has been informed that Gary Jacob, Chief Development Officer and Director, has acquired 30,980 of the Company’s ordinary shares on NASDAQ at $1.59, bringing his total holding to 108,920 shares.

ATLANTA, March 19, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three-month period and fiscal year ended January 3, 2026.

94% Increase in Q4 2025 Revenue to $6.2 Million

Education systems assessed using rigorous framework measuring excellence, equity, and efficiency

Plasma torches reduce energy requirements, melting times, dross generation, and cycle times in aluminum casthouse furnaces

SAN DIEGO, March 19, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, today announced financial results for the fourth quarter and full year ended December 31, 2025.

Titan is positioning itself to establish the first domestic end-to-end natural graphite supply chain in the U.S. in over seventy years

Next‑generation facility highlights long‑standing partnership and accelerates logistics capabilities for Hasbro’s iconic global brands

First 10,000 PSI Wellhead System Win in Pakistan and New Orders in Oman and Indonesia Advance OMS's Global SWS Expansion Strategy

WILMINGTON, Del., March 19, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that it will host a conference call at 8:00am ET on Tuesday, March 24, 2026.

Merger with FullBeauty Brands expected to close in second quarter of Fiscal 2026

FREMONT, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- As some governments and large buyers move towards locking AI workloads into region-specific platforms, Southeast Asian legal-tech founders face a new crossroads when planning U.S. pilots, sales, and fundraising. Gartner predicted that platform lock-in‚ such as sovereign cloud and country-region artificial intelligence (AI) platforms‚ is expected to grow from 5% to 35% by 2027․ This could create compliance and commercial risks for Southeast Asian legal-tech startups seeking to enter the United States market․

Company to host enhanced first quarter fiscal 2026 results conference call in June providing multi-year financial framework post closing of the joint venture transaction with WHP Global

Fort Lauderdale, Florida, March 19, 2026 (GLOBE NEWSWIRE) -- Vine Hill Capital Investment Corp. (Nasdaq: VCIC) (the “Company” or “Vine Hill”), a special purpose acquisition company, today announced that the physical place of its extraordinary general meeting to be held on March 27, 2026 (the “Extraordinary General Meeting”), for the purpose of, among other things, considering and voting upon a proposal to approve, by ordinary resolution, the proposed business combination (the “Business Combination” and the other transactions contemplated by the Business Combination Agreement among CoinShares International Limited (“CoinShares”), Vine Hill, Odysseus Holdings Limited (“Odysseus Holdings”) and the other parties thereto (collectively, the “Transactions”)) among Vine Hill, CoinShares and Odysseus Holdings, has been changed to the offices of Paul Hastings LLP, 515 South Flower Street, 25th Floor, Los Angeles, California 90071. The Extraordinary General Meeting will also continue to be held virtually at https://www.cstproxy.com/vinehillcapital/2026. There is no change to the previously announced time and date of the Extraordinary General Meeting.  The time and date of the Extraordinary General Meeting is 10:00 a.m., Eastern Time (or 7:00 a.m., Pacific Time), on March 27, 2026.

LAS VEGAS, March 19, 2026 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, announced today that it plans to release its financial results for the fourth quarter ended December 31st, 2025, on March 25th, 2026, aftermarket.

This order marks the first Middle East deployment of SPARC AI's mobile tactical platform as GPS jamming across the region reaches crisis levels

VICTORIA, Seychelles, March 19, 2026 (GLOBE NEWSWIRE) -- MEXC, the world's fastest-growing digital asset exchange and a pioneer of true zero-fee trading, has kicked off a new round of exclusive reward events under its ongoing Referral Ambassador Program, offering eligible ambassadors a range of rewards across different ambassador levels.

BRATISLAVA, Slovakia, March 19, 2026 (GLOBE NEWSWIRE) -- ESET Research releases its latest deep dive into the EDR killer ecosystem, disclosing how attackers abuse vulnerable drivers. ESET’s report presents telemetry-backed insights into the environment that move past the commonly seen driver-centric approach. It documents how affiliates, not operators, shape tooling diversity, and how codebases routinely reuse and swap drivers. EDR killers are a fundamental part of modern ransomware intrusions; as such, affiliates prefer a short, reliable window to run encryptors rather than constantly modifying payloads. Furthermore, ESET researchers assess that at least some recently observed EDR killers exhibit traits strongly suggestive of AI-assisted generation. Grounded in ESET telemetry and incident investigations, the research is based on the analysis and tracking of almost 90 EDR killers actively used in the wild.

With more than 20 products now Clean Label Project Certified, the company continues to expand its leadership in clean, simple ingredients and rigorous third-party standardsNewly certified products include Beyond Steak® Filet, Beyond Ground™ Original and Beyond Immerse™ in Peach Mango, Orange Tangerine and Lemon Lime — the first ready-to-drink protein drinks to earn this distinction

- Earnings Call Scheduled for 8:00 a.m. ET on March 31, 2026

Shell plc, London, March 19, 2026

SINGAPORE, March 19, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that it will implement a reverse stock split of its ordinary shares at a ratio of 1-for-20 (the “Reverse Stock Split”). The Reverse Stock Split was approved by the Company’s Board of Directors in accordance with British Virgin Islands law. The Reverse Stock Split will take effect at market open on March 23, 2026, and the ordinary shares will trade on a post-split basis on the Nasdaq Capital Market under the Company’s existing trading symbol “EUDA” and will continue to trade under that symbol. The new CUSIP number for EUDA’s ordinary shares following the Reverse Stock Split will be G3142E147.

New portable gateway gives broadcasters instant, flexible ST2110 connectivity—anywhere, anytime—without ripping out existing SDI infrastructure

SAHUARITA, Ariz., March 19, 2026 (GLOBE NEWSWIRE) -- Torreon Group, Inc. (OTCID: NXTN) today announced that ABOA Real Estate has executed a purchase agreement for an $800,000 condominium in the prestigious North Palm Beach Country Club community, marking the division's first acquisition outside Arizona and establishing a beachhead in Florida's high-demand luxury rental market.

BEIJING, March 19, 2026 (GLOBE NEWSWIRE) -- Sunlands Technology Group (NYSE: STG) (“Sunlands” or the “Company”), a leader in China’s adult online education market and China’s adult personal interest learning market, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025.

SINGAPORE, March 19, 2026 (GLOBE NEWSWIRE) -- UP Fintech Holding Limited (NASDAQ: TIGR) (“UP Fintech” or the “Company”), a leading online brokerage firm focusing on global investors, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025.

LONDON, March 19, 2026 (GLOBE NEWSWIRE) -- United Bank for Africa (UK) Limited (“UBA UK”) and British International Investment plc (“BII”), the UK’s development finance institution and impact investor, today announced that they have signed a letter of intent to develop trade finance collaboration opportunities. The proposed initiative aims to expand access to trade and working capital facilities for businesses operating across Africa.

RANCHO CORDOVA, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced a significant funding commitment to support strategic initiatives within its viral vector business, while reaffirming its long-term growth strategy across three business units: small molecule, peptides, and viral vectors.

Nanterre, March 19, 2026 (GLOBE NEWSWIRE) --  NORTH ATLANTIC ENERGIES

BRATISLAVA, Slovakia, March 19, 2026 (GLOBE NEWSWIRE) -- WeRide (NASDAQ: WRD, HKEX: 0800), a global leader in autonomous driving technology, today announced its entry into Slovakia through a strategic partnership with ELEVATE Slovakia to deploy autonomous vehicles (AVs), launching the country’s first AV program. This national-level rollout represents Europe's first large-scale, multi-product autonomous driving commercial deployment. The move marks WeRide's fourth European market after France, Belgium, and Switzerland, expanding its global footprint to over 40 cities across 12 countries.

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 19, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced it will hold an oral presentation outlining new preclinical data on Radio-DARPins at the 3rd Global Radiopharmaceuticals Development Summit, taking place in Shanghai, China on March 19–20, 2026.

Kuopio, Finland, March 19, 2026 (GLOBE NEWSWIRE) -- GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness absence due to psychiatric reasons, a new study shows. The large register-based study was carried out in collaboration between the University of Eastern Finland, Karolinska Institutet in Stockholm and Griffith University in Australia.

SHENZHEN, China, March 19, 2026 (GLOBE NEWSWIRE) -- LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (NASDAQ: LX), a leading technology-empowered personal financial service enabler in China, today announced its unaudited financial results for the quarter ended December 31, 2025.

TORONTO and SINGAPORE, March 18, 2026 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, indirect majority shareholder of Abaxx Singapore Pte Ltd. (“Abaxx Singapore”), the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), today announced that Abaxx Singapore has joined the Singapore Bullion Market Association (“SBMA”) as a Local Associate Member.

NEW ORLEANS, La., March 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 8, 2026 to file lead plaintiff applications in a securities class action lawsuit against Driven Brands Holdings Inc. (NasdaqGS: DRVN) (“Driven” or the “Company”), if they purchased or otherwise acquired the Company’s shares between May 9, 2023 and February 24, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, March 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 11, 2026 to file lead plaintiff applications in a securities class action lawsuit against Trip.com Group Limited (NasdaqGS: TCOM) (“Trip.com” or the “Company”), if they purchased or otherwise acquired the Company’s securities between April 30, 2024 and January 13, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.

NEW ORLEANS, La., March 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 13, 2026 to file lead plaintiff applications in securities class action lawsuits against Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD), if they purchased or otherwise acquired the Company’s shares between August 1, 2024 and February 9, 2026, inclusive (the “Class Period”). These actions are pending in the United States District Court for the Eastern and Southern Districts of New York.

NEW ORLEANS, March 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 5, 2026 to file lead plaintiff applications in a securities class action lawsuit against Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NasdaqCM: SLNO), if they purchased or otherwise acquired the Company’s shares between March 26, 2025 and November 4, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

NEW ORLEANS, March 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 1, 2026 to file lead plaintiff applications in a securities class action lawsuit against Apollo Global Management, Inc. (NYSE: APO) (“Apollo” or the “Company”), if they purchased or otherwise acquired the Company’s securities between May 10, 2021 and February 21, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, March 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 24, 2026 to file lead plaintiff applications in a securities class action lawsuit against Navan, Inc. (“Navan” or the “Company”) (NasdaqGS: NAVN), if they purchased or otherwise acquired the Company’s shares pursuant and/or traceable to the Registration Statement and Prospectus (collectively, the “Offering Documents”) issued in connection with Navan’s October 2025 initial public offering (the “IPO”). This action is pending in the United States District Court for the Northern District of California.

NEW ORLEANS, March 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against Corcept Therapeutics Incorporated (NasdaqCM: CORT) (“Corcept” or the “Company”), if they purchased or otherwise acquired the Company’s shares between October 31, 2024 and December 30, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

NEW ORLEANS, March 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 20, 2026 to file lead plaintiff applications in a securities class action lawsuit against Enphase Energy, Inc. (“Enphase” or the “Company”) (NasdaqGM: ENPH), if they purchased or otherwise acquired the Company’s securities between April 22, 2025 and October 28, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

NEW ORLEANS, March 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against uniQure N.V. (NasdaqGS: QURE) (“uniQure” or the “Company”), if they purchased or otherwise acquired the Company’s shares between September 24, 2025 and October 31, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, March 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 6, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NasdaqGS: RARE), if they purchased or otherwise acquired the Company’s shares between August 3, 2023 and December 26, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, March 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 23, 2026 to file lead plaintiff applications in a securities class action lawsuit against BellRing Brands, Inc. (NYSE: BRBR), if they purchased or otherwise acquired the Company’s securities between November 19, 2024 and August 4, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

BUFFALO, NY, March 18, 2026 (GLOBE NEWSWIRE) -- Austin Air Systems, a U.S.-based manufacturer of medical-grade air purification systems, today announced the launch of the Austin Air Mold Solutions Summit, a national online educational event designed to improve public understanding of mold exposure, mold-related illness, and indoor environmental health. The free summit will officially launch on March 31, 2026, bringing together medical professionals, environmental specialists, and building science experts to provide science-informed educational insights for families and clinicians.

Santa Clara, CA and Kyoto, Japan, March 18, 2026 (GLOBE NEWSWIRE) -- ROHM Semiconductor U.S.A., LLC today announced its participation at APEC 2026, the premier event for the power electronics community. This year’s conference will be held at the Henry B. Gonzalez Convention Center in San Antonio, TX, from March 22–26.

LOS ANGELES, March 18, 2026 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ: HNST), a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults, today announced that Chief Financial Officer, Curtiss Bruce and Interim Head of Investor Relations, Chris Mandeville will participate in investor meetings at the 38th Annual ROTH Conference in Dana Point, California on Monday, March 23rd, 2026.

PISCATAWAY, N.J., March 18, 2026 (GLOBE NEWSWIRE) -- BHAV Acquisition Corp (the “Company” or “BHAV”) today announced the pricing of its initial public offering of 10,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one right. Each right entitles the holder to receive one-fourth (1/4) of one Class A ordinary share upon consummation of the Company’s initial business combination. In connection with the offering, $10.00 per unit will be deposited into a trust account with Continental Stock Transfer & Trust Company acting as trustee. The units are expected to trade on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “BHAVU” beginning on March 19, 2026. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to trade on Nasdaq under the symbols “BHAV” and “BHAVR,” respectively.

Lifepoint Health’s Russell Bailey and CVS Health’s Dana Prommel Strauss to Bring Additional Healthcare Depth to Bioliberty Board of Directors

NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- If you suffered a loss on your investment in Plug Power, Inc. (“Plug Power” or the “Company”) (NASDAQ:PLUG), contact Lauren Molinaro by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- If you have suffered a loss on your Driven Brands Holdings Inc. (“Driven” or the “Company”) (NASDAQ:DRVN) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

Based on the Strength of Unprecedented Results from the Positive Phase 1/2 Study in Adults Aged 50 and Older, Vaxcyte Advanced VAX-31 High Dose into Comprehensive Phase 3 Adult Program; Topline Data from the OPUS-1 Pivotal Noninferiority Trial Expected in the Fourth Quarter of 2026

Ausgrid Deploys Itron Solution to Ensure Grid Reliability and Compliance with Market Requirements

Ontario, CA, March 18, 2026 (GLOBE NEWSWIRE) -- CVB Financial Corp. (NASDAQ: CVBF) (the “Company”) announced a twenty cent ($0.20) per share cash dividend with respect to the first quarter of 2026. This dividend was approved at the Company’s regularly scheduled Board of Directors meeting held on March 18, 2026. The quarterly dividend will be payable on or about April 15, 2026, to shareholders of record as of April 01, 2026.

REYKJAVIK, Iceland, March 18, 2026 (GLOBE NEWSWIRE) --

NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Trip.com Group Limited (“Trip.com” or the “Company”) (NASDAQ:TCOM) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds NuScale Power Corporation (“NuScale” or the “Company”) (NYSE:SMR) investors of the April 20, 2026 lead plaintiff deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired NuScale Power Corporation securities between May 13, 2025 through November 6, 2025 (“the Class Period”).